Some really good info there Farrell. While at the moment we don't know the details of our protocol I do hope that it will be impressive and at least challenge the number of patients we see in many late stage trials.
And proven safer and much more effective!! So far I like the sound of IPIX working with BDD Pharma.
Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not predict the rates observed in a broader patient population in clinical practice.
News 
Market Data 
Discover 
AI
